**Background**
Hyperproliferative diseases, characterized by the uncontrolled growth and division of cells, encompass a wide range of pathological conditions, including various types of cancer and psoriasis. A critical driver of these disorders is angiogenesis, the physiological process through which new blood vessels form from pre-existing vessels. While essential for normal development, pathological angiogenesis provides the necessary nutrient and oxygen supply to support the rapid expansion of tumors and the progression of chronic inflammatory diseases. Consequently, targeting the molecular pathways that regulate cell proliferation and blood vessel formation has become a primary focus in the development of novel therapeutic agents. In this context, we will introduce a pyrrolotriazine derivative – 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine.
**Definition**
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine is a pyrrolotriazine derivative with the molecular formula C6H5BrN4 and a molecular weight of 213.04. According to the 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine description, this compound serves as a valuable tool for studying hyperproliferative disorders and diseases associated with angiogenesis.
**Biological Activity**
The 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine biological activity is centered on its utility as a scaffold for developing substituted 4-amino-pyrrolotriazine derivatives. These derivatives are designed to modulate pathways involved in abnormal cell growth and the recruitment of new vasculature. By utilizing the 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine technical information, researchers can explore its potential to inhibit the progression of 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine Cancer models by disrupting the mechanisms that drive angiogenesis. In conclusion, 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine is a potent pyrrolotriazine derivative applicable to the study of hyperproliferative and angiogenesis-related diseases.
Keywords
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine, 937046-98-5, Drug Derivative, Drug derivative, pyrrolotriazine derivative, hyperproliferative diseases, angiogenesis-related diseases, Inhibitor, inhibitor, inhibit
References